Inhibitors of V-ATPases: Old and new players

Journal of Experimental Biology

Volumn 212, Issue 3, 2009, Pages 341-346

  Huss, Markus ^a   Wieczorek, Helmut ^a  

^a UNIVERSITY OF OSNABRÜCK   (Germany)

Author keywords

Antibiotic inhibitors; Benzolactone enamides; H+ translocating vacuolar type ATPase; Indolyls; Macrolactones; Plecomacrolides; V ATPase

Indexed keywords

ALKENE; APICULAREN A; ARCHAZOLID A; BAFILOMYCIN A; CONCANAMYCIN A; CRUENTAREN A; FUSED HETEROCYCLIC RINGS; LACTONE; LOBATAMIDE A; MACROLIDE; OXIMIDINE I; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SALICYLIC ACID DERIVATIVE; SALICYLIHALAMIDE A; THIAZOLE DERIVATIVE;

BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; GENETICS; METABOLISM; REVIEW;

ALKENES; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING SITES; LACTONES; MACROLIDES; MOLECULAR STRUCTURE; SALICYLATES; THIAZOLES; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EUKARYOTA;

EID: 59149095897     PISSN: 00220949     EISSN: None     Source Type: Journal    
DOI: 10.1242/jeb.024067     Document Type: Review

References (67)

1. 14C] diazirinylbenzoic acid as a photoaffinity label for binding studies of V-ATPase inhibitors. European J. Org. Chem. 2007, 3870-3878.
2. +-ATPase: molecular structure and function, physiological roles and regulation. J. Exp. Biol. 209, 577-589.
3. Biasotti, B., Dallavalle, S., Merlini, L., Farina, C., Gagliardi, S., Parini, C. and Belfiore, P. (2003). Synthesis of photoactivable inhibitors of osteoclast vacuolar ATPase. Bioorg. Med. Chem. 11, 2247-2254.
4. Bowman, B. J. and Bowman, E. J. (2002). Mutations in subunit c of the vacuolar ATPase confer resistance to bafilomycin and identify a conserved antibiotic binding site. J. Biol. Chem. 277, 3965-3972.
5. Bowman, B. J., McCall, M. E., Baertsch, R. and Bowman, E. J. (2006). A model for the proteolipid ring and bafilomycin/concanamycin-binding site in the vacuolar ATPase of Neurospora crassa. J. Biol. Chem. 281, 31885-31893.
6. Bowman, E. J., Siebers, A. and Altendorf, K. (1988). Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc. Natl. Acad. Sci. USA 85, 7972-7976.
7. Bowman, E. J., Gustafson, K. R., Bowman, B. J. and Boyd, M. R. (2003). Identification of a new chondropsin class of antitumor compound that selectively inhibits V-ATPases. J. Biol. Chem. 278, 44147-44152.
8. Bowman, E. J., Graham, L. A., Stevens, T. H. and Bowman, B. J. (2004). The bafilomycin/concanamycin binding site in subunit c of the V-ATPases from Neurospora crassa and Saccharomyces cerevisiae. J. Biol. Chem. 279, 33131-33138.
9. +-ATPases. J. Pharmacol. Exp. Ther. 297, 114-120.
10. Cantrell, C. L., Gustafson, K. R., Cecere, M. R., Pannell, L. K. and Boyd, M. R. (2000). Chondropsins A and B: novel tumor cell growth-inhibitory macrolide lactams from the marine sponge Chondropsis sp. J. Am. Chem. Soc. 122, 8825-8829.
11. + channel of vacuolar proton pumps. J. Biol. Chem. 269, 17379-17381.
12. +-ATPase enzymes. Org. Biomol. Chem. 1, 4361-4363.
13. Dixon, N., Pali, T., Kee, T. P. and Marsh, D. (2004). Spin-labelled vacuolar-ATPase inhibitors in lipid membranes. Biochim. Biophys. Acta 1665, 177-183.
14. O-sector. Biophys. J. 94, 506-514.
15. Dröse, S. and Altendorf, K. (1997). Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. J. Exp. Biol. 200, 1-8.
16. Dröse, S., Bindseil, K. U., Bowman, E. J., Siebers, A., Zeeck, A. and Altendorf, K. (1993). Inhibitory effect of modified bafilomycins and concanamycins on P- and V-type adenosinetriphosphatases. Biochemistry 32, 3902-3906.
17. Dröse, S., Boddien, C., Gassel, M., Ingenhorst, G., Zeeck, A. and Altendorf, K. (2001). Semisynthetic derivatives of concanamycin A and C, as inhibitors of V- and P-type ATPases: structure-activity investigations and developments of photoaffinity probes. Biochemistry 40, 2816-2825.
18. Erickson, K. L., Beutler, J. A., Cardellina, I. J. and Boyd, M. R. (1997). Salicylihalamides A and B, novel cytotoxic macrolides from the marine sponge Haliclona sp. J. Org. Chem. 62, 8188-8192.
19. Farès, C., Hassfeld, J., Menche, D. and Carlomagno, T. (2008). Simultaneous determination of the conformation and relative configuration of archazolide A by using nuclear Overhauser effects, J couplings, and residual dipolar couplings. Angew. Chem. Inter. Ed. Engl. 47, 3722-3726.
20. +-ATPase inhibitors with lipid bilayers. Biochemistry 45, 5271-5279.
21. Fernandes, F., Loura, L. M., Fedorov, A., Dixon, N., Kee, T. P., Prieto, M. and Hemminga, M. A. (2006b). Binding assays of inhibitors towards selected V-ATPase domains. Biochim. Biophys. Acta 1758, 1777-1786.
22. Forgac, M. (2007). Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat. Rev. Mol. Cell. Biol. 8, 917-929.
23. +-ATPase. J. Med. Chem. 41, 1883-1893.
24. +-ATPase of osteoclasts with bone antiresorptive activity. J. Med. Chem. 41, 1568-1573.
25. +-ATPase. Curr. Med. Chem. 6, 1197-1212.
26. Galinis, D. L., McKee, T. C., Pannell, L. K., Cardellina, J. H. and Boyd, M. R. (1997). Lobatamides A and B, novel cytotoxic macrolides from the tunicate Aplidium lobatum. J. Org. Chem. 62, 8968-8969.
27. 1. Biochem. Biophys. Res. Commun. 170, 873-878.
28. Hassfeld, J., Fares, C., Steinmetz, H., Carlomagno, T. and Menche, D. (2006). Stereochemical determination of Archazolid A and B, highly potent vacuolar-type ATPase inhibitors from the myxobacterium Archangium gephyra. Org. Lett. 8, 4751-4754.
29. Hilgenbrink, A. R. and Low, P. S. (2005). Folate receptor-mediated drug targeting: from therapeutics to diagnostics. J. Pharm. Sci. 94, 2135-2146.
30. Hinton, A., Bond, S. and Forgac, M. (2007). V-ATPase functions in normal and disease processes. Pflugers Arch. doi:10.1007/s00424-007-0382- 4.
31. O subunit c. J. Biol. Chem. 277, 40544-40548.
32. Huss, M., Sasse, F., Kunze, B., Jansen, R., Steinmetz, H., Ingenhorst, G., Zeeck, A. and Wieczorek, H. (2005). Archazolid and apicularen: novel specific V-ATPase inhibitors. BMC Biochem. 6, 13.
33. +-ATPase, inhibits vacuolar acidification and affects glycoprotein processing. FEBS Lett. 359, 53-59.
34. Kim, J. W., Shin-Ya, K., Furihata, K., Hayakawa, Y. and Seto, H. (1999). Oximidines I and II: novel antitumor macrolides from Pseudomonas sp. J. Org. Chem. 64, 153-155.
35. Kinashi, H., Sakaguchi, K., Higashijima, T. and Miyazawa, T. (1982). Structures of concanamycins B and C. J. Antibiot. 35, 1618-1620.
36. Kinashi, H., Someno, K. and Sakaguchi, K. (1984). Isolation and characterization of concanamycins A, B and C. J. Antibiot. 37, 1333-1343.
37. Kunze, B., Jansen, R., Sasse, F., Höfle, G. and Reichenbach, H. (1998). Apicularens A and B, new cytostatic macrolides from Chondromyces species (myxobacteria): production, physico-chemical and biological properties. J. Antibiot. 51, 1075-1080.
38. Kunze, B., Steinmetz, H., Hofle, G., Huss, M., Wieczorek, H. and Reichenbach, H. (2006). Cruentaren, a new antifungal salicylate-type macrolide from Byssovorax cruenta (myxobacteria) with inhibitory effect on mitochondrial ATPase activity. Fermentation and biological properties. J. Antibiot. 59, 664-668.
39. Kunze, B., Sasse, F., Wieczorek, H. and Huss, M. (2007). Cruentaren A, a highly cytotoxic benzolactone from myxobacteria is a novel selective inhibitor of mitochondrial F1-ATPases. FEBS Lett. 581, 3523-3527.
40. Mayer, T. and Maier, M. E. (2007). Design and synthesis of a tag-free chemical probe for photoaffinity labeling. European J. Org. Chem. 2007, 4711-4720.
41. McKee, T. C., Galinis, D. L., Pannell, L. K., Cardellina, J. H., Laakso, J., Ireland, C. M., Murray, L., Capon, R. J. and Boyd, M. R. (1998). The lobatamides, novel cytotoxic macrolides from southwestern pacific tunicates. J. Org. Chem. 63, 7805-7810.
42. Menche, D., Hassfeld, J., Sasse, F., Huss, M. and Wieczorek, H. (2007a). Design, synthesis, and biological evaluation of novel analogues of archazolid: a highly potent simplified V-ATPase inhibitor. Bioorg. Med. Chem. Lett. 17, 1732-1735.
43. Menche, D., Hassfeld, J., Steinmetz, H., Huss, M., Wieczorek, H. and Sasse, F. (2007b). Archazolid-7-O-beta-D-glucopyranoside-Isolation, structural elucidation and solution conformation of a novel V-ATPase inhibitor from the myxobacterium Cystobacter violaceus. European J. Org. Chem. 2007, 1196-1202.
44. Menche, D., Hassfeld, J., Steinmetz, H., Huss, M., Wieczorek, H. and Sasse, F. (2007c). The first hydroxylated archazolid from the myxobacterium Cystobacter violaceus: isolation, structural elucidation and V-ATPase inhibition. J. Antibiot. 60, 328-331.
45. Murata, T., Yamato, I., Kakinuma, Y., Leslie, A. G. and Walker, J. E. (2005). Structure of the rotor of the V-Type Na+-ATPase from Enterococcus hirae. Science 308, 654-659.
46. +- translocating ATPase. Biochem. Biophys. Res. Commun. 205, 1358-1365.
47. Nadler, G., Morvan, M., Delimoge, I., Belfiore, P., Zocchetti, A., James, I., Zembryki, D., Lee-Rycakzewski, E., Parini, C., Consolandi, E. et al. (1998). (2Z,4E)-5-(5,6-dichloro-2-indolyl)-2-methoxy-N-(1,2,2,6,6- pentamethylpiperidin-4-yl)-2,4-pentadienamide, a novel, potent and selective inhibitor of the osteoclast V-ATPase. Bioorg. Med. Chem. Lett. 8, 3621-3626.
48. Pali, T., Dixon, N., Kee, T. P. and Marsh, D. (2004a). Incorporation of the V-ATPase inhibitors concanamycin and indole pentadiene in lipid membranes. Spin-label EPR studies. Biochim. Biophys. Acta. 1663, 14-18.
49. O-sector. Biochemistry 43, 12297-12305.
50. Petri, A. F., Sasse, F. and Maier, M. E. (2005). Synthesis and biological evaluation of apicularen A analogues. European J. Org. Chem. 2005, 1865-1875.
51. Rashid, M. A., Cantrell, C. L., Gustafson, K. R. and Boyd, M. R. (2001). Chondropsin D, a new 37-membered-ring macrolide lactam from the marine sponge Chondropsis species. J. Nat. Prod. 64, 1341-1344.
52. Rautiala, T. J., Koskinen, A. M. and Vaananen, H. K. (1993). Purification of vacuolar ATPase with bafilomycin C1 affinity chromatography. Biochem. Biophys. Res. Commun. 194, 50-56.
53. Sasse, F., Steinmetz, H., Höfle, G. and Reichenbach, H. (2003). Archazolids, new cytotoxic macrolactones from Archangium gephyra (Myxobacteria). Production, isolation, physico-chemical and biological properties. J. Antibiot. 56, 520-525.
54. -symporters that uncouple proton translocators. J. Biol. Chem. 273, 21455-21462.
55. Schrama, D., Reisfeld, R. A. and Becker, J. C. (2006). Antibody targeted drugs as cancer therapeutics. Nat. Rev. Drug. Discov. 5, 147-159.
56. Shen, R., Lin, C. T., Bowman, E. J., Bowman, B. J. and Porco, J. A., Jr (2002). Synthesis and V-ATPase inhibition of simplified lobatamide analogues. Org. Lett. 4, 3103-3106.
57. Shen, R., Lin, C. T., Bowman, E. J., Bowman, B. J. and Porco, J. A., Jr (2003). Lobatamide C: total synthesis, stereochemical assignment, preparation of simplified analogues, and V-ATPase inhibition studies. J. Am. Chem. Soc. 125, 7889-7901.
58. Shen, R., Inoue, T., Forgac, M. and Porco, J. A., Jr (2005). Synthesis of photoactivatable acyclic analogues of the lobatamides. J. Org. Chem. 70, 3686-3692.
59. Sørensen, M. G., Henriksen, K., Neutzsky-Wulff, A. V., Dziegiel, M. H. and Karsdal, M. A. (2007). Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption. J. Bone Miner. Res. 22, 1640-1648.
60. 1 is a potassium ionophore that impairs mitochondrial functions. J. Bioenerg. Biomembr. 39, 321-329.
61. Wang, Y., Inoue, T. and Forgac, M. (2005). Subunit a of the yeast V-ATPase participates in binding of bafilomycin. J. Biol. Chem. 280, 40481-40488.
62. Werner, G., Hagenmaier, H., Drautz, H., Baumgartner, A. and Zahner, H. (1984). Metabolic products of microorganisms. 224. Bafilomycins, a new group of macrolide antibiotics. Production, isolation, chemical structure and biological activity. J. Antibiot. 37, 110-117.
63. Whitehurst, A. W., Bodemann, B. O., Cardenas, J., Ferguson, D., Girard, L., Peyton, M., Minna, J. D., Michnoff, C., Hao, W., Roth, M. G. et al. (2007). Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature 446, 815-819.
64. +-ATPase bind with high affinity to the purified proteolipid subunit of the membrane domain. Biochemistry 44, 15024-15031.
65. Wieczorek, H., Brown, D., Grinstein, S., Ehrenfeld, J. and Harvey, W. R. (1999). Animal plasma membrane energization by proton motive V-ATPases. BioEssays 21, 637-648.
66. 1. J. Biol. Chem. 279, 19755-19763.
67. O domain of the coated vesicle V-ATPase. J. Biol. Chem. 269, 23518-23523.